Researchers use magnetic nanoparticles and liquid-handling robots in an effort to detect COVID-19 outbreaks early.

Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.

Abbott’s ID NOW test missed the most positive samples among five products given the green light by the FDA to use during the pandemic.

The University of Massachusetts Amherst is supplying local hospitals and the state with key ingredients needed for COVID-19 testing.

Scientists at academic labs equipped to test for SARS-CoV-2 report that multiple barriers are preventing from them from operating at full capacity.

An inflatable biosafety laboratory may help meet the global need for testing infrastructure during the COVID-19 pandemic.

The University of Washington department of laboratory medicine in Seattle processes a backlog of COVID-19 samples.

The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.

Scientists engineered a new material that could be developed for use in treating tooth decay.

This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

The blood-testing company must respond to the US Centers for Medicare and Medicaid Services’ allegations of substandard conditions at one of its labs.

The Association for Molecular Pathology finds fault in the agency’s report on safety issues associated with certain lab tests.

The US Food and Drug Administration cites cases in which laboratory-developed tests “may have caused or have caused actual harm to patients.”

So-called laboratory-developed tests will eventually face regulations similar to those that currently govern diagnostic tests or kits that are sold to hospitals.